MedTrace Logo

Ovarian Hyperstimulation Syndrome Using Calcium Infusion

NCT05198128 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2022-02-22

No results posted yet for this study

Summary

the incidence of OHSS and clinical outcomes after calcium IV infusion in high-risk women undergoing ART

Conditions

  • Ovarian Hyperstimulation Syndrome

Interventions

DRUG

Calcium intravenous infsuion

intravenous infusion of 10 % calcium gluconate 10 mL in 200 mL of physiologic saline on the day of ovum pickup, day 1,day 2, and day 3 after ovum pickup were administered in study group. Intravenous infusion was performed within 30 minutes

DRUG

0.9 % saline

0.9 % saline

Sponsors & Collaborators

  • Al-Azhar University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2023-04-25
Completion
2023-05-10

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05198128 on ClinicalTrials.gov